This page tracks new and upcoming treatment options for postural orthostatic tachycardia syndrome (POTS). What’s in development? What’s promising? What’s available soon? Current topics include GSK-126, EZH2 inhibitors, IVIG, ivabradine, moxonidine, pyridostigmine, albumin, propranolol, and more.

Subscribe